Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIMA/FDA meeting

This article was originally published in The Gray Sheet

Executive Summary

The board of the Health Industry Manufacturers Association met with members of the Center for Devices and Radiological Health Dec. 8 in Washington, D.C. Representatives of the device center included Director Bruce Burlington, Deputy Director for Regulation and Policy Joseph Levitt, Deputy Director for Science Elizabeth Jacobsen, and Director of the Office of Device Evaluation Susan Alpert, according to HIMA staffers. During the meeting, HIMA President Alan Magazine articulated the association's position that there are fundamental problems with the philosophy at CDRH that need to be addressed, including the center's intrusion into the practice of medicine, law enforcement mentality, and adversarial attitude toward the U.S. device industry
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel